ArticleNature reviews. Clinical oncology2019
Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphoma.
Alvaro J Alencar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleNature reviews. Clinical oncology2019
Alvaro J Alencar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.